2MURDOCH D, PLOSKER G. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation [ J ]. Drugs, 2006,66 (5) :671-692.
3MATIAS-GUIU J, FERRO J,ALVAREZ-SABIN J, et al. Co- mparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction:the TACIP study: a randomized, double-blind, multicenter trial [ J ]. Stroke, 2003,34(4) : 840-848.
4CRUZ-FERNANDEZ J, LOPEZ-BESCOS L, GARCIA-DOR- ADO D, et al. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction [ J ]. Eur HeartJ,2000,21 (6) : 457-465.
5PEREZ-GOMEZ F, EDURADO A, JOSE A, et al. Compara- tive effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation:a randomized multieenter study[J]. J Am Coil Cardiol, 2004, 44 (8) : 1557-1566.
2Murdoch D,Plosker G.Triflusal:a review of its use in cerebral infarction and myocardial infarction,and as thromboprophylaxis in atrial fibrillation.Drugs,2006,66(5):671-692.
3BP(英国药典).2005.Ph Eur monograph,1377.
4国家药典委员会.中国药典(二部)[s].北京:中国医药科技出版社,2010:附录29,60.
5McNeely W,Goa K. Triflusal[J]. Drugs,1998,55(6) :823-833.
6Murdoch D,Plosker G L. Triflusal:A review of its use in cerebral infarction and myocardial infarction,and as thromboprophylaxis in atrial fibrillation[J]. Drugs,2006,66(5) :671-692.
7European Pharmacopoeia Commission Strasbourg: European Di rectorate for the Quality of Medicine Health Care EP7. 0 [S].2010:3137-3138.
1ANNINOS H, ANDRIKOPOULOS G, PASTROM ASS, et al. Triflusal: An old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness[ J]. Hellenic J Cardiol, 2009,50(3) :199 -207.
2MURDOCH D, PLOSKER GL. Triflusal: A review of its use in cerevral infarction and myocardial infarction, and as thrombopro- phylaxis in atrial fibrillation [ J ]. Drugs, 2006,66 ( 5 ) : 671 - 692.
3QUETGLAS EG, CAMPANERO biA, SADABA B, et al. Bio- equivalence of two oral formulationa of triflusal capsules in health- y volunteers [ J ]. Arznelmittel-Forschung ( Drug Research ) , 2008, 58(6) :283 -287.
4CHO HY, JEONG TJ, LEE YB. Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluorom- ethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography[ J ]. J Chromatogr B Analyt Technol Bi- omed Life Sci,2003, 798(2) :257 -264.
5IZQUIERDO I, BORJA J, ROVIRA S, et al. Comparative bio- availability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study [ J]. Arzneimittelforschung, 2010, 60 (1) :36 -41.
